<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004127A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004127</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13966185</doc-number><date>20130813</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>24</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>16</main-group><subgroup>249</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241581</main-classification><further-classification>5303892</further-classification></classification-national><invention-title id="d0e43">Human Anti-IFN-gamma Neutralizing Antibodies as Selective IFN-gamma Pathway Inhibitors</invention-title><us-related-documents><division><relation><parent-doc><document-id><country>US</country><doc-number>13476317</doc-number><date>20120521</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8529893</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13966185</doc-number></document-id></child-doc></relation></division><division><relation><parent-doc><document-id><country>US</country><doc-number>12831087</doc-number><date>20100706</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8202976</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>13476317</doc-number></document-id></child-doc></relation></division><division><relation><parent-doc><document-id><country>US</country><doc-number>11962594</doc-number><date>20071221</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>7790859</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>12831087</doc-number></document-id></child-doc></relation></division><continuation><relation><parent-doc><document-id><country>US</country><doc-number>10684957</doc-number><date>20031014</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>7335743</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>11962594</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>60479241</doc-number><date>20030617</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>60419057</doc-number><date>20021016</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Welcher</last-name><first-name>Andrew A.</first-name><address><city>Ventura</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Chute</last-name><first-name>Hilary T.</first-name><address><city>Calabasas</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Li</last-name><first-name>Yue-Sheng</first-name><address><city>Thousand Oaks</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Huang</last-name><first-name>Haichun</first-name><address><city>Fremont</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Welcher</last-name><first-name>Andrew A.</first-name><address><city>Ventura</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Chute</last-name><first-name>Hilary T.</first-name><address><city>Calabasas</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Li</last-name><first-name>Yue-Sheng</first-name><address><city>Thousand Oaks</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Huang</last-name><first-name>Haichun</first-name><address><city>Fremont</city><state>CA</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>MEDAREX, INC.</orgname><role>02</role><address><city>Princeton</city><state>NJ</state><country>US</country></address></addressbook></assignee><assignee><addressbook><orgname>AMGEN INC.</orgname><role>02</role><address><city>Thousand Oaks</city><state>CA</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">This invention provides antibodies that interact with or bind to human interferon-gamma (IFN-&#x3b3;) and methods for treating IFN-&#x3b3; mediated diseases by administering a pharmaceutically effective amount of antibodies to IFN-&#x3b3;. Methods of detecting the amount of IFN-&#x3b3; in a sample using antibodies to IFN-&#x3b3; are also provided.</p></abstract></us-patent-application>